ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Gene editing in agriculture & food: Accelerating the second green revolution – Cleantech Group

Genetic Literacy ProjectGene editing in agriculture & food: Accelerating the second green revolutionCleantech GroupPressure on global resources to support our food system is growing, and even outpacing ability to meet demand. Genetic engineering is… Continue reading

2018-03-16 Michael Zand NEWS

Here’s Why Amyris Stock Jumped as Much as 28.5% Higher Today – Madison.com

Continue reading

2018-03-16 Michael Zand NEWS

Here’s Why Amyris Stock Jumped as Much as 28.5% Higher Today – Madison.com


Madison.com

Here’s Why Amyris Stock Jumped as Much as 28.5% Higher Today
Madison.com
Shares of synthetic biology pioneer Amyris (NASDAQ: AMRS) soared over 28% today after the company announced fourth-quarter and full-year 2017 earnings. The company reported 113% revenue growth in 2017 compared to 2016, guided for up to $195 million in …
Noteworthy Stocks to Watch for: Amyris, Inc. (NASDAQ:AMRS), Guess’, Inc. (NYSE:GES)The Oracle Examiner
Amyris (AMRS) Upgraded at Zacks Investment Researchregistrarjournal.com

all 13 news articles »

Continue reading

2018-03-16 Michael Zand NEWS

Clinical trial to test efficacy of stem cell transplants in stopping ALS muscle deterioration – News-Medical.net

News-Medical.netClinical trial to test efficacy of stem cell transplants in stopping ALS muscle deteriorationNews-Medical.netThis is possible because adult stem cells from the bone marrow act as guards and prevent the death of motor neurons (named as s… Continue reading

2018-03-16 Michael Zand NEWS

Here’s an ETF to Invest in Immunotherapy–the Game Changing Cancer Treatment – Nasdaq


Madison.com

Here’s Why Amyris Stock Jumped as Much as 28.5% Higher Today
Madison.com
Shares of synthetic biology pioneer Amyris (NASDAQ: AMRS) soared over 28% today after the company announced fourth-quarter and full-year 2017 earnings. The company reported 113% revenue growth in 2017 compared to 2016, guided for up to $195 million in …
Noteworthy Stocks to Watch for: Amyris, Inc. (NASDAQ:AMRS), Guess’, Inc. (NYSE:GES)The Oracle Examiner
Amyris (AMRS) Upgraded at Zacks Investment Researchregistrarjournal.com

all 13 news articles »

Continue reading

2018-03-16 Michael Zand NEWS

Here’s Why Amyris Stock Jumped as Much as 28.5% Higher Today – Fox Business


Nasdaq

Here’s an ETF to Invest in Immunotherapy–the Game Changing Cancer Treatment
Nasdaq
In this episode of ETF Spotlight, I talked with Brad Loncar, CEO of Loncar Investments, who created the Loncar Cancer Immunotherapy Index, the underlying benchmark for the Loncar Cancer Immunotherapy ETF CNCR . Immunotherapy is often called a game …

Continue reading

2018-03-16 Michael Zand NEWS

Dr. Moore on Challenges With Immunotherapy in Ovarian Cancer – OncLive

Dr. Moore on Challenges With Immunotherapy in Ovarian CancerOncLiveKathleen N. Moore, MD, assistant professor, Stephenson Cancer Center, The University of Oklahoma, discusses challenges with immunotherapy agents in the treatment of patients with ovaria… Continue reading

2018-03-16 Michael Zand NEWS

Dr. Moore on Challenges With Immunotherapy in Ovarian Cancer – OncLive

Dr. Moore on Challenges With Immunotherapy in Ovarian CancerOncLiveKathleen N. Moore, MD, assistant professor, Stephenson Cancer Center, The University of Oklahoma, discusses challenges with immunotherapy agents in the treatment of patients with ovaria… Continue reading

2018-03-16 Michael Zand NEWS
  • 1
  • …
  • 389
  • 390
  • 391
  • 392
  • 393
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

registrarjournal.com

Here’s Why Amyris Stock Jumped as Much as 28.5% Higher Today
Fox Business
Shares of synthetic biology pioneer Amyris (NASDAQ: AMRS) soared over 28% today after the company announced fourth-quarter and full-year 2017 earnings. The company reported 113% revenue growth in 2017 compared to 2016, guided for up to $195 million in …
Noteworthy Stocks to Watch for: Amyris, Inc. (NASDAQ:AMRS), Guess’, Inc. (NYSE:GES)The Oracle Examiner
Amyris (AMRS) Upgraded at Zacks Investment Researchregistrarjournal.com
The Amyris (AMRS) Posts Earnings Results, Beats Expectations By $0.54 EPSBangaloreWeekly

all 7 news articles »